Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Most patients with type 1 diabetes using an inhaled insulin increased their daily insulin dose by more than 4 U from baseline ...

Adolescent hyperglycemia and worsening insulin resistance are associated with an increased risk for worsening structural and functional cardiac damage.

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of ...

Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has gained attention in various research studies ...

While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...

Should you exercise differently if you’re on a GLP-1 weight loss drug such as Ozempic or Wegovy? Here’s what to know about which physical activities best support your health goals.

News Evidence That GLP-1 Drugs Achieve Weight Loss Primarily by Reducing Fat Mass More Than Muscle. Diabetes and obesity have become pressing health issues worldwide. Glucagon-lik ...

Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One ...